InsiderFinancial
Long

$MDCO Breaks Out, Expect Further Gains

NASDAQ:MDCO   None
$MDCO has been having a banner year with the stock up over 200%. We think this rally still has legs and that $MDCO is going to keep climbing after Monday's huge breakout. Here's a look at what drove Monday's breakout.

Results from a Phase 3 clinical trial, ORION-9, evaluating the effect of The Medicines Company's (MDCO +2.3%) inclisiran on reducing "bad" cholesterol (LDL-C) in patients with familial hypercholesterolemia (FH), an inherited condition characterized by abnormally high levels of cholesterol in the blood, showed a treatment benefit. The data were presented at the American Heart Association Scientific Sessions in Philadelphia.

The study met the primary endpoints of percent change in LDL-C from baseline to day 510 (50% reduction) versus placebo and time-averaged percent change (45% reduction) in LDL-C after day 90 up to day 510 versus control. Both values were statistically significant.

No new safety signals were observed.

The results will be submitted for presentation in a peer-reviewed medical journal. The company expects to file a U.S. marketing application this quarter and one in Europe next quarter.

The company will host a conference call today at 12 noon ET to discuss the results from ORION-9 and ORION-10.

In other news, there are also rumblings this morning that Novartis (NYSE:NVS) may be circling.

As always, use protective stops and trade with caution.

Good luck to all!
Nov 25
Trade closed: target reached: Gains of 42% in a week.

Congrats to all who participated!
To receive our alerts via email and SMS, join Insider Financial for Free at https://signup.insiderfinancial.com

We are not financial advisors. Always conduct your own research and read our full disclaimer at https://insiderfinancial.com/disclaimer/
Home Stock Screener Forex Screener Crypto Screener Economic Calendar Shows How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out